France issues a warning about the desogestrel-based contraceptive
Around 1.6 million women who have taken a desogestrel-based contraceptive pill (the brands Antigone, Cerazette, Elfasette, and Optimizette) will receive a personalized email to inform them, as a precaution, of the “very slight increase in risk” of developing meningioma, a tumor in the meninges, generally benign.